Other clinical studies found that the expression of NEAT1 was upregulated in peripheral blood mononuclear cells (PBMCs) from patients with HCC and could interfere with Tim-3 expression by binding to miR-155. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.